Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy

Published:2016-05-19 Issue:8 Volume:5 Page:e1188244
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Azuma Masahiro,Takeda Yohei,Nakajima Hiroko,Sugiyama Haruo,Ebihara Takashi,Oshiumi Hiroyuki,Matsumoto Misako,Seya Tsukasa

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1188244

Reference52 articles.

1. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton

2. Cross-presentation by dendritic cells

3. Innate Immune Recognition of Cancer

4. Transcriptional regulation of myeloid-derived suppressor cells

5. The interaction of anticancer therapies with tumor-associated macrophages

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revitalizing antitumor immunity: Leveraging nucleic acid sensors as therapeutic targets;Cancer Letters;2024-04

2. Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy;Journal of Pharmaceutical Investigation;2023-09

3. Cell‐Based Drug Delivery Systems Participate in the Cancer Immunity Cycle for Improved Cancer Immunotherapy;Small;2022-11-27

4. Toll-like receptor-targeted anti-tumor therapies: Advances and challenges;Frontiers in Immunology;2022-11-21

5. Recombinant MUC1-MBP fusion protein combined with CpG2006 vaccine induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice;Immunology Letters;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3